ALZMETA.APP: ONLINE META-ANALYSIS OF MONOCLONAL ANTIBODIES AGAINST AMYLOID-BETA PEPTIDES IN LARGE PHASE III CLINICAL TRIALS IN ALZHEIMER'S DISEASE

ALZMETA.APP: ONLINE META-ANALYSIS OF MONOCLONAL ANTIBODIES AGAINST AMYLOID-BETA PEPTIDES IN LARGE PHASE III CLINICAL TRIALS IN ALZHEIMER'S DISEASE

Bibliographic Details
Main Authors:	Danko Jeremic, Juan D. Navarro-López, Lydia Jiménez-Díaz
Format:	Article
Language:	English
Published:	Elsevier 2023-10-01
Series:	IBRO Neuroscience Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667242123008874

Similar Items

The consequences of mitochondrial amyloid beta-peptide in Alzheimer's disease.
by: Muirhead, K, et al.
Published: (2010)

Effectiveness and safety of monoclonal antibodies against amyloid-beta vis-à-vis placebo in mild or moderate Alzheimer's disease
by: Ying Hao, et al.
Published: (2023-03-01)

Amyloid-beta peptide and tau protein crosstalk in Alzheimer’s disease
by: Alejandro R Roda, et al.
Published: (2022-01-01)

Anti-Amyloid-β Monoclonal Antibodies: Recent Therapeutic Strategies for Alzheimer’s Disease
by: Maria Teresa Cruz, et al.
Published: (2022-03-01)

Prophylaxis and treatment of Alzheimer's disease by delivery of an adeno-associated virus encoding a monoclonal antibody targeting the amyloid Beta protein.
by: Masaru Shimada, et al.
Published: (2013-01-01)

Beta-sheet structured oligomers of Alzheimer's beta-amyloid peptide perturb phosphatidylcholine model membranes
by: de Planque, M, et al.
Published: (2006)

Amyloid fibril formation by a synthetic peptide from a region of human acetylcholinesterase that is homologous to the Alzheimer's amyloid-beta peptide.
by: Cottingham, MG, et al.
Published: (2002)

Molecular docking studies on the interaction of anti-alzheimer compounds with amyloid beta peptides
by: Faujan, Nur Hana, et al.
Published: (2019)

Potential Role of Nanoparticles in Treating the Accumulation of Amyloid-Beta Peptide in Alzheimer’s Patients
by: Mohamed Abbas
Published: (2021-03-01)

Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer’s disease
by: Randall J. Bateman, et al.
Published: (2022-11-01)

Amyloid beta and Alzheimer’s Disease: The role of neprilysin-2 in amyloid-beta clearance
by: Robert eMarr, et al.
Published: (2014-08-01)

Amyloid Beta in Aging and Alzheimer’s Disease
by: Ujala Sehar, et al.
Published: (2022-10-01)

Verbenalin Reduces Amyloid-Beta Peptide Generation in Cellular and Animal Models of Alzheimer’s Disease
by: Juhee Lim, et al.
Published: (2022-12-01)

Antibody binding of amyloid beta peptide epimers/isomers and ramifications for immunotherapies and drug development
by: Elizabeth R. Readel, et al.
Published: (2023-07-01)

Circular RNA Encoded Amyloid Beta peptides—A Novel Putative Player in Alzheimer’s Disease
by: Dingding Mo, et al.
Published: (2020-09-01)

Beta-Amyloid Peptide in Tears: An Early Diagnostic Marker of Alzheimer’s Disease Correlated with Choroidal Thickness
by: Magda Gharbiya, et al.
Published: (2023-01-01)

Monoclonal Antibody Therapy in Alzheimer’s Disease
by: Monica Neațu, et al.
Published: (2023-12-01)

Amyloid-beta and tau protein beyond Alzheimer’s disease
by: Morteza Abyadeh, et al.
Published: (2024-01-01)

Natural Products Targeting Amyloid Beta in Alzheimer’s Disease
by: Joo-Hee Lee, et al.
Published: (2021-02-01)

Optical Imaging of Beta-Amyloid Plaques in Alzheimer’s Disease
by: Ziyi Luo, et al.
Published: (2021-07-01)

The Use of Monoclonal Antibodies in the Treatment of Alzheimer Disease
by: Hemen Moradi-Sardareh, et al.
Published: (2016-09-01)

Development of monoclonal antibody therapeutics for alzheimer's disease
by: Masatoshi Takeda
Published: (2022-01-01)

Aducanumab and lecanemab – two novel antibodies against pathologic species of amyloid beta in the treatment of Alzheimer’s disease
by: Jakub Wojcieszak
Published: (2023-05-01)

Anti-amyloid: An antibody to cure Alzheimer’s or an attitude
by: Olivia M. Osborne, et al.
Published: (2023-08-01)

Fibronectin type III domain-containing protein 5 interacts with APP and decreases amyloid β production in Alzheimer’s disease
by: Yasuha Noda, et al.
Published: (2018-10-01)

Human-like rodent amyloid-beta-peptide determines Alzheimer pathology in aged wild-type Octodon degu.
by: Inestrosa, N, et al.
Published: (2005)

In silico study of traditional Chinese medicinal compounds targeting alzheimer's disease amyloid beta-peptide (1–42)
by: V. Naveen Kumar, et al.
Published: (2023-12-01)

Folding simulation of amyloid β-peptide in alzheimer's disease.
by: Koh, Jessica Li Jian.
Published: (2010)

TREM2 Expression and Amyloid-Beta Phagocytosis in Alzheimer’s Disease
by: Francesca La Rosa, et al.
Published: (2023-05-01)

Editorial: Beta-Amyloid oligomer specific treatments for Alzheimer's disease
by: Heinz Hillen
Published: (2023-01-01)

Oligodendrocytes damage in Alzheimer's disease: Beta amyloid toxicity and inflammation
by: ALEJANDRO D ROTH, et al.
Published: (2005-01-01)

Simvastatin Efficiently Reduces Levels of Alzheimer’s Amyloid Beta in Yeast
by: Sudip Dhakal, et al.
Published: (2019-07-01)

Off-target binding of an anti-amyloid beta monoclonal antibody to platelet factor 4 causes acute and chronic toxicity in cynomolgus monkeys
by: Lise I. Loberg, et al.
Published: (2021-01-01)

Alzheimer’s Amyloid Hypothesis and Antibody Therapy: Melting Glaciers?
by: Poul F. Høilund-Carlsen, et al.
Published: (2024-03-01)

Alzheimer’s Amyloid Hypothesis and Antibody Therapy: Melting Glaciers?
by: Høilund-Carlsen, Poul F., et al.
Published: (2024)

Molecular simulation between amyloid beta (1-42), a Peptide associated with alzheimer disease, and zinc(ii) ion
by: Abdul Ghani, Nur Syafiqah
Published: (2016)

Molecular Dynamics Simulations of Acetylcholinesterase – Beta-Amyloid Peptide Complex
by: Atanasova Mariana, et al.
Published: (2020-12-01)

Recombinant amyloid beta-peptide production by coexpression with an affibody ligand
by: Dobson Christopher M, et al.
Published: (2008-10-01)

GALECTIN-3 REDUCES AMYLOID BETA PLAQUE AND ASSOCIATED DYSTROPHIES ON APP MICE
by: Jesús Soldán Hidalgo, et al.
Published: (2023-10-01)

Neuronal Rubicon Represses Extracellular APP/Amyloid β Deposition in Alzheimer’s Disease
by: Sandra Espinoza, et al.
Published: (2022-06-01)